EFFECTS OF ANTIHYPERTENSIVE THERAPY ON COGNITIVE DECLINE AND BIOCHEMICAL MARKERS IN HYPERTENSIVE PATIENTS WITH INCREASED RISK FOR ALZHEIMER’S DISEASE Article Swipe
Javeria Sarfraz
,
I. A. Mustafa
,
Muhammad Tahir
,
Muhammad Usman
,
Zobia Mushtaq
,
Waleed Arshad
,
Farah Naz Tahir
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.53555/77hdmt29
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.53555/77hdmt29
Related Topics
Concepts
Disease
Medicine
Cognitive decline
Cognition
Cognitive impairment
Internal medicine
Dementia
Psychiatry
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.53555/77hdmt29
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4410260101
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4410260101Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.53555/77hdmt29Digital Object Identifier
- Title
-
EFFECTS OF ANTIHYPERTENSIVE THERAPY ON COGNITIVE DECLINE AND BIOCHEMICAL MARKERS IN HYPERTENSIVE PATIENTS WITH INCREASED RISK FOR ALZHEIMER’S DISEASEWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-05-10Full publication date if available
- Authors
-
Javeria Sarfraz, I. A. Mustafa, Muhammad Tahir, Muhammad Usman, Zobia Mushtaq, Waleed Arshad, Farah Naz TahirList of authors in order
- Landing page
-
https://doi.org/10.53555/77hdmt29Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.53555/77hdmt29Direct OA link when available
- Concepts
-
Disease, Medicine, Cognitive decline, Cognition, Cognitive impairment, Internal medicine, Dementia, PsychiatryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4410260101 |
|---|---|
| doi | https://doi.org/10.53555/77hdmt29 |
| ids.doi | https://doi.org/10.53555/77hdmt29 |
| ids.openalex | https://openalex.org/W4410260101 |
| fwci | 0.0 |
| type | article |
| title | EFFECTS OF ANTIHYPERTENSIVE THERAPY ON COGNITIVE DECLINE AND BIOCHEMICAL MARKERS IN HYPERTENSIVE PATIENTS WITH INCREASED RISK FOR ALZHEIMER’S DISEASE |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10144 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9053000211715698 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Blood Pressure and Hypertension Studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779134260 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6998192667961121 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[0].display_name | Disease |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6593775153160095 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2984863031 |
| concepts[2].level | 4 |
| concepts[2].score | 0.5888462066650391 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q83030 |
| concepts[2].display_name | Cognitive decline |
| concepts[3].id | https://openalex.org/C169900460 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4857524037361145 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2200417 |
| concepts[3].display_name | Cognition |
| concepts[4].id | https://openalex.org/C2984915365 |
| concepts[4].level | 3 |
| concepts[4].score | 0.42559078335762024 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q5141203 |
| concepts[4].display_name | Cognitive impairment |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4155155122280121 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C2779483572 |
| concepts[6].level | 3 |
| concepts[6].score | 0.30462074279785156 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q83030 |
| concepts[6].display_name | Dementia |
| concepts[7].id | https://openalex.org/C118552586 |
| concepts[7].level | 1 |
| concepts[7].score | 0.2145475447177887 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[7].display_name | Psychiatry |
| keywords[0].id | https://openalex.org/keywords/disease |
| keywords[0].score | 0.6998192667961121 |
| keywords[0].display_name | Disease |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6593775153160095 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/cognitive-decline |
| keywords[2].score | 0.5888462066650391 |
| keywords[2].display_name | Cognitive decline |
| keywords[3].id | https://openalex.org/keywords/cognition |
| keywords[3].score | 0.4857524037361145 |
| keywords[3].display_name | Cognition |
| keywords[4].id | https://openalex.org/keywords/cognitive-impairment |
| keywords[4].score | 0.42559078335762024 |
| keywords[4].display_name | Cognitive impairment |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.4155155122280121 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/dementia |
| keywords[6].score | 0.30462074279785156 |
| keywords[6].display_name | Dementia |
| keywords[7].id | https://openalex.org/keywords/psychiatry |
| keywords[7].score | 0.2145475447177887 |
| keywords[7].display_name | Psychiatry |
| language | en |
| locations[0].id | doi:10.53555/77hdmt29 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Population Therapeutics and Clinical Pharmacology |
| locations[0].landing_page_url | https://doi.org/10.53555/77hdmt29 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5087426294 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Javeria Sarfraz |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Javeria Sarfraz |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5113527650 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | I. A. Mustafa |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Iram Mustafa |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5100689309 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2937-5645 |
| authorships[2].author.display_name | Muhammad Tahir |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Muhammad Tahir |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5017888360 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-9324-6947 |
| authorships[3].author.display_name | Muhammad Usman |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Muhammad Usman |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5021829411 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Zobia Mushtaq |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Zobia Mushtaq |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5068362235 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Waleed Arshad |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Waleed Arshad |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5009691782 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Farah Naz Tahir |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Farah Naz Tahir |
| authorships[6].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.53555/77hdmt29 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | EFFECTS OF ANTIHYPERTENSIVE THERAPY ON COGNITIVE DECLINE AND BIOCHEMICAL MARKERS IN HYPERTENSIVE PATIENTS WITH INCREASED RISK FOR ALZHEIMER’S DISEASE |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10144 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9053000211715698 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Blood Pressure and Hypertension Studies |
| related_works | https://openalex.org/W2409059799, https://openalex.org/W364817481, https://openalex.org/W1481122508, https://openalex.org/W4390605164, https://openalex.org/W2208745537, https://openalex.org/W2614083263, https://openalex.org/W4308959407, https://openalex.org/W3217516093, https://openalex.org/W4393946798, https://openalex.org/W1990182404 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.53555/77hdmt29 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Population Therapeutics and Clinical Pharmacology |
| best_oa_location.landing_page_url | https://doi.org/10.53555/77hdmt29 |
| primary_location.id | doi:10.53555/77hdmt29 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Population Therapeutics and Clinical Pharmacology |
| primary_location.landing_page_url | https://doi.org/10.53555/77hdmt29 |
| publication_date | 2025-05-10 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 7 |
| citation_normalized_percentile.value | 0.26304558 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |